The deal affirms Blackstone's vision of building companies around innovative products to meet unmet patient needs Blackstone Life Sciences and Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced today that Novartis has completed its acquisition of Anthos Therapeutics in a transaction valued at up to $3.1 billion. Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialize abelacimab, a novel Factor XI inhibitor that originated at Novartis. Abelacimab is currently in Phase

Blackstone (NYSE:BX) announced today that the Blackstone Private Multi-Asset Credit and Income Fund (BMACX) has been declared effective by the U.S. Securities and Exchange Commission. This marks a significant milestone for BMACX, which will aim to provide individual investors a one-stop, private multi-asset credit solution designed to access strategies across Blackstone's $453 billion credit platform through an interval fund structure. BMACX will invest across private corporate credit, asset based and real estate credit, structured credit and liquid credit. BMACX builds on Blackstone's leadership position delivering private credit solutions to individual investors, with dedicated vehicles

Blackstone (NYSE:BX) today announced the final close of its most recent real estate debt fund, Blackstone Real Estate Debt Strategies V ("BREDS V"), which has approximately $8 billion of total capital commitments. Tim Johnson, Global Head of Blackstone Real Estate Debt Strategies, said, "We are extraordinarily appreciative of our investors for allocating this amount of capital during this period of market dislocation. We could not be more enthusiastic about the opportunities ahead and with the support of the largest owner of commercial real estate as well as the largest alternative real estate credit platform in the world, BREDS V is well-positioned to deliver in this attractive vintage."

UBS upgraded Blackstone from Neutral to Buy and set a new price target of $180.00

Wells Fargo downgraded Blackstone from Overweight to Equal Weight and set a new price target of $195.00 from $188.00 previously

TD Cowen upgraded Blackstone from Hold to Buy and set a new price target of $230.00 from $149.00 previously

4 - Blackstone Inc. (0001393818) (Issuer)

4 - Blackstone Inc. (0001393818) (Issuer)

4 - Blackstone Inc. (0001393818) (Issuer)

4 - Blackstone Inc. (0001393818) (Issuer)

4 - Blackstone Inc. (0001393818) (Issuer)

4 - Blackstone Inc. (0001393818) (Issuer)

8-K - Blackstone Inc. (0001393818) (Filer)

S-8 - Blackstone Inc. (0001393818) (Filer)

IRANNOTICE - Blackstone Inc. (0001393818) (Filer)

Blackstone (NYSE:BX) announced today that Rodney Zemmel – a long-time Senior Partner at McKinsey, who served as the global leader of both McKinsey Digital and the firm's AI Transformation initiatives – has been appointed Global Head of Portfolio Operations. Mr. Zemmel will oversee Blackstone's Portfolio Operations group, a team of operating executives that provides expertise and support to Blackstone's portfolio companies across a wide range of functional areas to help create value for our investors. These include talent, data science and AI transformation, cybersecurity, group procurement, energy efficiency, operational excellence, and asset management – helping partner with company CEOs

NEW YORK, Feb. 10, 2025 /PRNewswire/ -- Acushnet Holdings Corp. (NYSE:GOLF) will replace Retail Opportunity Investments Corp. (NASD: ROIC) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 13. S&P 500 constituent Blackstone Inc. (NYSE:BX) is acquiring Retail Opportunity Investments in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Feb 13, 2025 S&P SmallCap 600 Addition Acushnet Holdings GOLF Consumer Discretionary Feb 13, 2025 S&P SmallCap 600 Delet

Chris James Appointed Global Head of Tac Opps, David Blitzer to Transition to Chairman Jas Khaira to be Head of Tac Opps Americas, Qasim Abbas to be Head of Tac Opps International Blackstone (NYSE:BX) announced today that Chris James – currently Chief Operating Officer (COO) and a founding member of Blackstone Tactical Opportunities ("Tac Opps"), with nearly two decades of experience at Blackstone – will become Global Head of Tac Opps. He will succeed David Blitzer, who will transition to chairman of the business at year end. Blackstone also today announced the elevation of two long-time senior Tac Opps partners to expanded leadership roles for the business. Jas Khaira will be Head of Ta

The deal affirms Blackstone's vision of building companies around innovative products to meet unmet patient needs Blackstone Life Sciences and Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced today that Novartis has completed its acquisition of Anthos Therapeutics in a transaction valued at up to $3.1 billion. Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialize abelacimab, a novel Factor XI inhibitor that originated at Novartis. Abelacimab is currently in Phase

Growth investment made in partnership with Asian American Hotel Owners Association (AAHOA) M3, LLC ("M3"), voted the number-one hospitality accounting software in North America, today announced it has signed a definitive agreement for a majority investment from Blackstone Growth and affiliated funds (collectively "Blackstone"). The investment will help to accelerate the company's growth by enhancing new product expansion and supporting the adoption of M3's software, which enables hotel operators to run more efficiently and effectively. AAHOA, representing nearly 20,000 hotel owners and 60% of hotels across the United States, will make its first ever strategic investment alongside Blacksto

Blackstone (NYSE:BX) announced today that private equity funds managed by Blackstone ("Blackstone") have completed the acquisition of Tropical Smoothie Cafe, a leading franchisor of fast casual restaurants, from Levine Leichtman Capital Partners. This marks the first transaction in Blackstone's most recent vintage of its flagship private equity vehicle. "Tropical Smoothie Cafe is a nationally recognized brand with an impressive growth trajectory underpinned by a base of loyal franchisees and guests," said Peter Wallace, a Senior Managing Director, and Michael Staub, a Managing Director, in Blackstone's Private Equity business. "With Blackstone's capital and resources, we look forward to a

SC 13G - Blackstone Inc. (0001393818) (Subject)

SC 13G/A - Blackstone Inc. (0001393818) (Subject)

SC 13G - Blackstone Inc. (0001393818) (Subject)